Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Lactate and lactylation in cancer
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Mitochondrial Sirtuins in Cancer: A Revisited Review from Molecular Mechanisms to Therapeutic Strategies
Hui Shen, Wei Ma, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2993-3013
Open Access | Times Cited: 7
Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective
Basant Elaasser, Nour Arakil, Khalid S. Mohammad
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2846-2846
Open Access | Times Cited: 5
Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways
Yu Zhang, Hailong Lun, Naiqiang Zhu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Repurposing Brucine as a Chemopreventive Agent in Mammary Gland Carcinoma: Regulating Lactate Transport through MCT-4
A. Zaidi, Anurag Kumar, Rohit Kumar, et al.
Toxicology Reports (2025) Vol. 14, pp. 101902-101902
Open Access
Self‐Sustained Biophotocatalytic Nano‐Organelle Reactors with Programmable DNA Switches for Combating Tumor Metastasis
Wenshuai Han, Jiang‐Qiao Ding, Bo Qiao, et al.
Advanced Materials (2025)
Open Access
Metabolic programming of pancreatic and colon cancer
Sridevi Mardham, Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 325-340
Closed Access
Mechanistic insights into the role of traditional Chinese medicine in treating gastric cancer
Ziqiang Chen, Ting Yu, Yunhe Wang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Intranuclear TCA and mitochondrial overload: the nascent sprout of tumors metabolism
Weixi Yuan, Guozhong Lu, Yin Zhao, et al.
Cancer Letters (2025), pp. 217527-217527
Closed Access
Ldha Accelerates Primary Cisplatin Resistance in Lung Adenocarcinoma by Modulating Ambra1 Ubiquitination Via Moonlighting Functions
Fengguo Xu, Qiang Wang, Ying Zhang, et al.
(2025)
Closed Access
Lactoferrin-Encapsulated Dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancer
Sugarniya Subramaniam, Varinder Jeet, Jennifer H. Gunter, et al.
Cancer Letters (2025), pp. 217522-217522
Closed Access
HSP90 co-regulates the formation and nuclear distribution of the glycolytic output complex to promote resistance and poor prognosis in gastric cancer patients
Gaigai Shen, Shiya Liu, Yuanting Cao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Huachansu suppresses colorectal cancer via inhibiting PI3K/AKT and glycolysis signaling pathways: Systems biology and network pharmacology
Hongxuan YANG, Yixu Chen, Chun-Lan Dai, et al.
Journal of Ethnopharmacology (2025), pp. 119479-119479
Closed Access
Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities
Bitian Zhang, Ping‐Chung Leung, William C. Cho, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Transplantation of gastric epithelial mitochondria into human gastric cancer cells inhibits tumor growth and enhances chemosensitivity by reducing cancer stemness and modulating gastric cancer metabolism
Hsin‐Yi Tsai, Kuen-Jang Tsai, Deng-Chyang Wu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer
Fang Ren, Xiaoao Pang, Feng Jin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Study on the Mechanism of Jieduquyuziyin prescription Improving the Condition of MRL/lpr Mice by Regulating T Cell Metabolic Reprogramming through the AMPK/mTOR Pathway
Qingmiao Zhu, Yaxue Han, Xiaolong Li, et al.
Journal of Ethnopharmacology (2025) Vol. 345, pp. 119584-119584
Closed Access
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies
Jinshou Yang, Feihan Zhou, Xiyuan Luo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Targeted mitochondrial therapy for pancreatic cancer
Xinya Zhao, Guoyu Wu, Xufeng Tao, et al.
Translational Oncology (2025) Vol. 54, pp. 102340-102340
Closed Access
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications
Xiaowen Xie, Weici Liu, Zhiyuan Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Metabolic reprogramming in cancer and senescence
Yuzhu Zhang, J. Tang, Can Jiang, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Unspliced XBP1 enhences metabolic reprogramming in colorectal cancer cells by interfering with the mitochondrial localization of MGME1
Jiandong Zhang, Suyang Zhang, Fei Yu, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151613-151613
Closed Access
Paraoxonase‐2 shRNA‐mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines
Valentina Schiavoni, Monica Emanuelli, Roberto Campagna, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 7
Closed Access | Times Cited: 1
Exploring the Interplay between the Warburg Effect and Glucolipotoxicity in Cancer Development: A Novel Perspective on Cancer Etiology
Maher M. Akl, Amr Ahmed
Advanced Pharmaceutical Bulletin (2024) Vol. 14, Iss. 3, pp. 705-713
Open Access | Times Cited: 1
USP27 promotes glycolysis and hepatocellular carcinoma progression by stabilizing PFKFB3 through deubiquitination
Longhui Xie, Dekun Song, Z. Ouyang, et al.
Cellular Signalling (2024) Vol. 127, pp. 111585-111585
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top